93 related articles for article (PubMed ID: 5091160)
1. Evidence for inhibition of the reuptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine in rat brain.
Bruinvels J
Br J Pharmacol; 1971 Jun; 42(2):281-6. PubMed ID: 5091160
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 5-hydroxytryptamine uptake by tetrahydronorharmane in vivo.
Rommelspacher H; Strauss S; Cohnitz CH
Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):229-33. PubMed ID: 150545
[TBL] [Abstract][Full Text] [Related]
3. The effects of cinepazide on the content, biosynthesis and turnover of noradrenaline, dopamine and 5-hydroxytryptamine in the rat brain under room air and hypoxia.
Miwa S; Fujiwara M; Lee K; Fujiwara M
Jpn J Pharmacol; 1986 May; 41(1):109-15. PubMed ID: 2426499
[TBL] [Abstract][Full Text] [Related]
4. Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla.
Hammond DL; Tyce GM; Yaksh TL
J Physiol; 1985 Feb; 359():151-62. PubMed ID: 2582112
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
Fagervall I; Kelder D; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
[TBL] [Abstract][Full Text] [Related]
6. Time course of changes in serotonin and noradrenaline in rat brain after predictable or unpredictable shock.
Adell A; Trullas R; Gelpi E
Brain Res; 1988 Aug; 459(1):54-9. PubMed ID: 2458804
[TBL] [Abstract][Full Text] [Related]
7. Role of noradrenaline and 5-hydroxytryptamine in tetrahydronaphthylamine-induced temperature changes in the rat.
Bruinvels J; Kemper GC
Br J Pharmacol; 1971 Sep; 43(1):1-9. PubMed ID: 4257629
[TBL] [Abstract][Full Text] [Related]
8. Ifoxetine, a compound with atypical effects on serotonin uptake.
Waldmeier PC; Maître L; Baumann PA; Hauser K; Bischoff S; Bittiger H; Paioni R
Eur J Pharmacol; 1986 Oct; 130(1-2):1-10. PubMed ID: 2877890
[TBL] [Abstract][Full Text] [Related]
9. Model of central chemical 'serotoninectomy' in mice.
Herman ZS; Bonczek A
Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
[TBL] [Abstract][Full Text] [Related]
10. Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro.
Carlsson A; Fuxe K; Hamberger B; Malmfors T
Br J Pharmacol; 1969 May; 36(1):18-28. PubMed ID: 5768100
[TBL] [Abstract][Full Text] [Related]
11. Regional and subcellular changes in the concentration of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat brain caused by hydrocortisone, DL- -methyl-tryptophan l-kynurenine and immobilization.
Curzon G; Green AR
Br J Pharmacol; 1971 Sep; 43(1):39-52. PubMed ID: 5136463
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic levels and utilization of noradrenaline and 5-hydroxytryptamine in the sodium-depleted rat.
Munaro N; Chiaraviglio E
Pharmacol Biochem Behav; 1981 Jul; 15(1):1-5. PubMed ID: 6170073
[TBL] [Abstract][Full Text] [Related]
13. Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release.
Stenfors C; Ross SB
Psychopharmacology (Berl); 2004 Mar; 172(2):119-28. PubMed ID: 14735290
[TBL] [Abstract][Full Text] [Related]
14. Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching.
Tanii H; Huang J; Hashimoto K
Brain Res; 1993 Oct; 626(1-2):265-71. PubMed ID: 7506631
[TBL] [Abstract][Full Text] [Related]
15. Uptake of 5-hydroxytryptamine in rat isolated atria.
el Rawadi C; Heimburger M; Davy M; Midol-Monnet M; Beslot F; Cohen Y
Gen Pharmacol; 1992 Jul; 23(4):613-7. PubMed ID: 1383073
[TBL] [Abstract][Full Text] [Related]
16. Dextromethorphan inhibits 5-hydroxytryptamine uptake by human blood platelets and decreases 5-hydroxyindoleacetic acid content in rat brain.
Ahtee L
J Pharm Pharmacol; 1975 Mar; 27(3):177-80. PubMed ID: 238000
[TBL] [Abstract][Full Text] [Related]
17. Role of serotoninergic and adrenergic mechanisms in the action of prominal.
Nowakowska E; Godlewski J
Acta Physiol Pol; 1979; 30(5-6):581-7. PubMed ID: 93847
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
[TBL] [Abstract][Full Text] [Related]
19. The action of 2-amino-tetralin (beta-tetrahydronaphthylamine) on the metabolism of 5-hydroxytryptamine in the brain of the mouse.
Robinson D; Sharman DF
Br J Pharmacol Chemother; 1967 Mar; 29(3):335-41. PubMed ID: 4382327
[No Abstract] [Full Text] [Related]
20. The effect of noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats.
Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1976; 28(4):341-7. PubMed ID: 135973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
